ABOUT CASES OF ACUTE POISONING WITH AMITRIPTYLINE
Abstract
Amitriptyline is a tricyclic antidepressant (TCA) widely used in medical practice for the treatment of depression, chronic neuropathic pain, migraine prophylaxis, and certain anxiety disorders. It possesses a narrow therapeutic index, and even a moderate excess of the therapeutic dose can lead to severe, potentially fatal toxicity. In clinical and forensic practice, cases of acute poisoning with amitriptyline are among the most common causes of fatal outcomes associated with antidepressant overdose. The toxic effects are primarily related to its pronounced anticholinergic, membrane-stabilizing (quinidine-like), and alpha-adrenergic blocking properties, which manifest as cardiac arrhythmias, hypotension, seizures, and central nervous system depression. Amitriptyline is extensively metabolized in the liver to its active metabolite nortriptyline, and both compounds are strongly bound to plasma proteins and tissues, which complicates their isolation and quantitative determination in biological material. According to data reported in the literature, fatal poisonings with tricyclic antidepressants, including amitriptyline, continue to be registered, often in combination with alcohol or other psychoactive substances, which further aggravates the clinical course.